Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

1.

Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities: An emerging hypothesis for neuropathy and gastrointestinal toxicity.

Wardill HR, Van Sebille YZ, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST.

Cancer Treat Rev. 2015 Feb;41(2):122-128. doi: 10.1016/j.ctrv.2014.11.005. Epub 2014 Dec 5. Review.

PMID:
25512119
[PubMed - as supplied by publisher]
2.

Of Marfan's syndrome, mice, and medications.

Bowen JM, Connolly HM.

N Engl J Med. 2014 Nov 27;371(22):2127-8. doi: 10.1056/NEJMe1412950. Epub 2014 Nov 18. No abstract available.

PMID:
25405389
[PubMed - indexed for MEDLINE]
3.

Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study.

Coller JK, White IA, Logan RM, Tuke J, Richards AM, Mead KR, Karapetis CS, Bowen JM.

Support Care Cancer. 2014 Oct 16. [Epub ahead of print]

PMID:
25318697
[PubMed - as supplied by publisher]
4.

Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.

Al-Azri AR, Gibson RJ, Bowen JM, Stringer AM, Keefe DM, Logan RM.

J Oral Pathol Med. 2014 Sep 12. doi: 10.1111/jop.12255. [Epub ahead of print]

PMID:
25213123
[PubMed - as supplied by publisher]
5.

Development of the rat model of lapatinib-induced diarrhoea.

Bowen JM.

Scientifica (Cairo). 2014;2014:194185. doi: 10.1155/2014/194185. Epub 2014 Jul 7. Review.

PMID:
25126444
[PubMed]
Free PMC Article
6.

Determining the mechanisms of lapatinib-induced diarrhoea using a rat model.

Bowen JM, Mayo BJ, Plews E, Bateman E, Wignall A, Stringer AM, Boyle FM, Keefe DM.

Cancer Chemother Pharmacol. 2014 Sep;74(3):617-27. doi: 10.1007/s00280-014-2519-4. Epub 2014 Jul 24.

PMID:
25055934
[PubMed - indexed for MEDLINE]
7.

Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.

O'Reilly DJ, Bowen JM, Sebaldt RJ, Petrie A, Hopkins RB, Assasi N, MacDougald C, Nunes E, Goeree R.

Ont Health Technol Assess Ser. 2014 Apr 1;14(3):1-37. eCollection 2014.

PMID:
24748911
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.

Bowen JM, Perry AM, Laurini JA, Smith LM, Klinetobe K, Bast M, Vose JM, Aoun P, Fu K, Greiner TC, Chan WC, Armitage JO, Weisenburger DD.

Br J Haematol. 2014 Jul;166(2):202-8. doi: 10.1111/bjh.12880. Epub 2014 Apr 4.

PMID:
24697285
[PubMed - indexed for MEDLINE]
9.

New pharmacotherapy options for chemotherapy-induced alimentary mucositis.

Wardill HR, Bowen JM, Gibson RJ.

Expert Opin Biol Ther. 2014 Mar;14(3):347-54. doi: 10.1517/14712598.2014.874412. Epub 2014 Jan 6.

PMID:
24387716
[PubMed - in process]
10.

Systematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients.

Nam J, Caners K, Bowen JM, Welsford M, O'Reilly D.

Ann Emerg Med. 2014 Aug;64(2):176-86, 186.e1-9. doi: 10.1016/j.annemergmed.2013.11.016. Epub 2013 Dec 22. Review.

PMID:
24368054
[PubMed - indexed for MEDLINE]
11.

A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada.

Whelan JP, Bowen JM, Burke N, Woods EA, McIssac GP, Hopkins RB, O'Reilly DJ, Xie F, Sehatzadeh S, Levin L, Mathew SP, Patterson LL, Goeree R, Tarride JE.

Can Urol Assoc J. 2013 Sep-Oct;7(9-10):335-41. doi: 10.5489/cuaj.180.

PMID:
24319513
[PubMed]
Free PMC Article
12.

Irinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity.

Wardill HR, Bowen JM, Al-Dasooqi N, Sultani M, Bateman E, Stansborough R, Shirren J, Gibson RJ.

Cancer Biol Ther. 2014 Feb;15(2):236-44. doi: 10.4161/cbt.27222. Epub 2013 Dec 6.

PMID:
24316664
[PubMed - indexed for MEDLINE]
13.

TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?

Wardill HR, Gibson RJ, Logan RM, Bowen JM.

Int J Cancer. 2014 Dec 1;135(11):2483-92. doi: 10.1002/ijc.28656. Epub 2014 Jan 10. Review.

PMID:
24310924
[PubMed - indexed for MEDLINE]
14.

Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.

Chambers A, Bowen JM.

Ont Health Technol Assess Ser. 2013 Oct 1;13(18):1-37. eCollection 2013. Review.

PMID:
24228081
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Access to surgery for paediatric patients with medically refractory epilepsy: a systems analysis.

Lim ME, Bowen JM, Snead OC 3rd, Elliott I, Donner E, Weiss SK, Otsubo H, Ochi A, Drake J, Rutka JT, Worster A, Hopkins RB, Goeree R, Tarride JE.

Epilepsy Res. 2013 Dec;107(3):286-96. doi: 10.1016/j.eplepsyres.2013.08.010. Epub 2013 Sep 2. Review.

PMID:
24192043
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario.

Goeree R, Blackhouse G, Bowen JM, O'Reilly D, Sutherland S, Hopkins R, Chow B, Freeman M, Provost Y, Dennie C, Cohen E, Marcuzzi D, Iwanochko R, Moody A, Paul N, Parker JD.

Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):675-90. doi: 10.1586/14737167.2013.838079.

PMID:
24138652
[PubMed - indexed for MEDLINE]
17.

Photoselective vaporization for the treatment of benign prostatic hyperplasia.

Bowen JM, Whelan JP, Hopkins RB, Burke N, Woods EA, McIsaac GP, O'Reilly DJ, Xie F, Sehatzadeh S, Levin L, Mathew SP, Patterson LL, Goeree R, Tarride JE.

Ont Health Technol Assess Ser. 2013 Aug 1;13(2):1-34. eCollection 2013.

PMID:
24019857
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis.

O'Reilly D, Pasricha A, Campbell K, Burke N, Assasi N, Bowen JM, Tarride JE, Goeree R.

Int J Technol Assess Health Care. 2013 Jul;29(3):269-81. doi: 10.1017/S0266462313000263. Review.

PMID:
23863187
[PubMed - indexed for MEDLINE]
19.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3233-41. doi: 10.1007/s00520-013-1900-x. Epub 2013 Jul 11. Review.

PMID:
23842598
[PubMed - indexed for MEDLINE]
20.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21. Review.

PMID:
23604521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk